Genetic suppression and pharmacological inhibition of PGM3 by FR054, a competitive inhibitor of PGM3, impaired tumor growth and promoted the death of KL co-mutant NSCLC cells both in vitro and in vivo. The gene discussed is KL; the disease is non-small cell lung carcinoma.